Regulatory framework for biologicals

2 July 2018

The regulatory framework for biologicals provides the legislative basis for the regulation of human tissue and cell-derived products that are supplied, in or exported from, Australia.

The biologicals legislation commenced on 31 May 2011, following a recommendation from Commonwealth, State and Territory health ministers to improve the regulation of human tissues and cell-based therapies. All products within the scope of the framework need to comply with the requirements made under the legislation.

The framework applies different levels of regulation to products based on the risks associated with their use. The framework is designed to be flexible enough to accommodate emerging technologies.

Live animal cell, tissues or organs were added to the biologicals framework in 2017.

Changes to the regulation of autologous human cell and tissue products came into effect on 1 July 2018. Minor changes to the definitions and the classification rules for biologicals were also made.

For further information refer:


The legislation is available from: Legislation & legislative instruments. Regulation of biologicals is specified in:


Biologicals must conform to relevant standards:


Further information

There are various forms for the biologicals industry, with the application forms for including a biological in the ARTG available from TGA Business Services.

If you have any further queries or would like further information please contact the TGA.